Note: The job is a remote job and is open to candidates in USA. Kennedy Bond is partnering with an innovative biotechnology company on a unique consulting opportunity supporting the continued development of a first-in-class oncology asset. The consultant will play a key role in advancing a targeted oncology program, helping shape the next phase of development through IND planning, protocol development, translational strategy, and overall clinical development activities.
Responsibilities
- Lead development of IND-enabling and IND submission activities
- Contribute to clinical development strategy for a first-in-human oncology program
- Author and review clinical protocols and supporting study documentation
- Partner closely with translational and research teams to align clinical and scientific objectives
Skills
- Must hold at least a PhD degree with significant oncology drug development experience
- Prior first-in-human clinical development experience required
- Demonstrated experience building and filing IND packages
- Experience developing clinical protocols from early-stage assets and a strong translational medicine background
- Solid tumor experience required
- Breast cancer experience preferred
Company Overview
Kennedy Bond specializes in the life sciences search space, forming strategic partnerships with Biotech, Pharmaceutical companies, consulting firms and VC firms across the United States. It was founded in 2024, and is headquartered in New York, US, with a workforce of 2-10 employees. Its website is http://kennedybond.com.